Donanemab

Potential Breakthrough: New Alzheimer’s Medications Display Promise in Early Disease Stages

by

In a potential breakthrough, two novel Alzheimer’s drugs are showcasing encouraging outcomes in slowing down the progression of the disease during its early stages. Recent research has unveiled promising results about the effectiveness of a fresh Eli Lilly medication, known as Donanemab, in curbing the advancement of Alzheimer’s by approximately 35%. For individuals in the … Read more

Breakthrough Alzheimer’s Medication Slows Disease Progression by a third

by
alzheimer's disease HerbalGH

Experts Declare Imminent Availability of Alzheimer’s Drugs, Marking a Remarkable Shift from Previous Perceptions Donanemab, a drug developed by Eli Lilly, has demonstrated a significant 33% reduction in the progression of Alzheimer’s disease, prompting experts to describe the current stage as being “on the cusp” of groundbreaking treatments, an outcome that was deemed “impossible” not … Read more